Sales and Marketing

Showing 15 posts of 11526 posts found.

rsa

RSA appoints new managing director for RSA Germany

July 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kristian Juergensen, appointment, recruitment firm, rsa

RSA, the life sciences recruitment specialist, has appointed Kristian Juergensen as its new managing director of RSA in Germany. Juergensen …

GSK to pay ‘unprecedented’ $3 billion fraud charge

July 3, 2012 Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty

GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …
screen_shot_2012-07-03_at_14

Strategic North makes two appointments

July 3, 2012 Business Services, Medical Communications, Sales and Marketing Strategic North

Healthcare strategic marketing agency Strategic North has expanded its team with the appointments of Sandra Du Cross in the role …

FDA approves Astellas’ leaky bladder drug

July 3, 2012 Sales and Marketing Astellas, FDA, Myrbetriq, bladder, urology

The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq.   Myrbetriq (mirabegron), the first drug in its class, works …
GSK image

GSK and Theravance post COPD pill data

July 2, 2012 Research and Development, Sales and Marketing COPD, GSK, LABA, LAMA, Theravance

GSK and partner Theravance have released new data for its combination COPD drug. Results from four late-stage trials suggest that …
mark-porter-dr_2161169b

Doctors’ union the BMA appoints new chairman

July 2, 2012 Medical Communications, Research and Development, Sales and Marketing BMA, Dr Mark Porter, appointment

Dr Mark Porter, a consultant anaesthetist in Coventry, has been elected new chairman of the British Medical Association’s UK Council. …
LaMattina image

John LaMattina: FDA tries to disavow role in higher hurdles for new drugs

July 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug

As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012 Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
AZ image

AstraZeneca and BMS buy Amylin for $7 billion

July 2, 2012 Sales and Marketing Amylin, AstraZeneca, BMS

AstraZeneca and Bristol-Myers Squibb have struck a deal to purchase diabetes specialist Amylin in a complicated agreement worth $7 billion. …
ariad_slideshow-3

Ariad touts next generation CML treatment

June 29, 2012 Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland

Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …

Growth in health spending ‘grinds to a halt’

June 28, 2012 Business Services, Sales and Marketing Financial, GDP, OECD, growth, pharma

Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term …

DH admits cancer awareness campaigns failed

June 28, 2012 Sales and Marketing Cancer, Department of Health, GPs, government

The government’s £9 million cancer awareness campaigns were built upon failed pilots, according to newly released data. The national awareness …

US judges vote to keep Obamacare

June 28, 2012 Sales and Marketing Health reform, President Obama, US

The US Supreme Court will allow President Obama’s health reforms to stand.The nine-member Supreme Court has decided not to repeal …

ZS Associates elects new managing director

June 28, 2012 Business Services, Medical Communications, Sales and Marketing Chris Wright, ZS Associates

Sales and marketing consulting firm ZS Associates announced today that Chris Wright has been elected by firm partners to the …

Ireland agrees deal on medicines

June 28, 2012 Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing

Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …
The Gateway to Local Adoption Series

Latest content